SINT

Sintx Technologies, Inc.

NasdaqCMUSDEQUITY DELAYED

1.58

▲ 0.08 (5.28%)

MARKET · —

Price

Open

1.50

Prev close

1.50

Day high

1.58

Day low

1.49

Volume

24.11K

Market cap

—

P/E (TTM)

—

52W range

1.40 – 6.78

Trailing performance

Price return · vs SPY

Returnvs SPY

-5.49% -4.1%

+1.97% -1.8%

-32.61% -35.7%

-48.84% -59.9%

YTD

-59.84% -72.1%

-53.31% -73.3%

-99.35% -173.5%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

1.63

-3.12% from price

SMA 20

1.63

-4.94% from price

SMA 50

1.74

-10.98% from price

SMA 100

2.07

-23.75% from price

SMA 200

2.68

-42.17% from price

EMA 12

1.61

-1.91% from price

EMA 26

1.65

-4.24% from price

EMA 50

1.77

-10.61% from price

RSI (14)

43.9

Neutral

MACD (12,26,9)

-0.04

Hist -0.00

ATR (14)

0.14

8.85% of price

Realised vol 30D

83.6%

Annualised

Bollinger upper

1.79

20, 2σ

Bollinger lower

1.47

20, 2σ

50 / 200 cross

Death

1.74 vs 2.68

Trend bias

Below 200

-42.17%

Risk profile

Daily returns · 1Y window

Beta vs SPY

1.73

More volatile than market

Correlation to SPY

0.25

Largely independent

Realised vol 30D

83.6%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-74.6%

Peak to trough

Max drawdown 5Y

-100.0%

Peak to trough

ATR 14

0.14

8.85% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 1.58

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

SINT · links out to the publisher

SINTX TECHNOLOGIES (SINT) Moves to Buy: Rationale Behind the Upgrade Zacks · 3d ago SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement GlobeNewswire · 9d ago Sintx Technologies, Inc. Q2 2026 Earnings Call Summary Moby · 10d ago SINTX Technologies Inc (SINT) (Q2 2026) Earnings Call Highlights: Revenue Surges 199% as ... GuruFocus.com · 11d ago SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives GlobeNewswire · 11d ago LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates Zacks · 17d ago ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates Zacks · 19d ago AxoGen (AXGN) Tops Q2 Earnings and Revenue Estimates Zacks · 24d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.